Evidence map›Paper›PMID 36424487›Full record

ArticleNature biotechnology2023

Functional analysis of structural variants in single cells using Strand-seq.

Hyobin Jeong, Karen Grimes, Kerstin K Rauwolf, Peter-Martin Bruch, Tobias Rausch, Patrick Hasenfeld, Eva Benito, Tobias Roider, Radhakrishnan Sabarinathan, David Porubsky and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Nature biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Structural variant and nucleosome occupancy dynamics postchemotherapy in a HER2+ breast cancer organoid model.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 6 countries.

Hyobin Jeong *Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-1526-3343
Karen Grimes *Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-4805-2366
Kerstin K RauwolfDivision of Pediatric Oncology, University Children's Hospital, Zürich, Switzerland.
Peter-Martin BruchDepartment of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-9992-3109
Tobias RauschGenome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-5773-5620
Patrick HasenfeldGenome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.ORCID http://orcid.org/0000-0003-2319-2482
Eva BenitoGenome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
Tobias RoiderGenome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-6973-3531
Radhakrishnan SabarinathanNational Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India.
David PorubskyCenter for Bioinformatics, Saarland University, Saarbrücken, Germany.ORCID http://orcid.org/0000-0001-8414-8966
Sophie A HerbstDepartment of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-8502-0366
Büşra Erarslan-UysalMolecular Medicine Partnership Unit, European Molecular Biology Laboratory, University of Heidelberg, Heidelberg, Germany.
Johann-Christoph JannDepartment of Hematology and Oncology, Medical Faculty Mannheim of the Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-2200-0151
Tobias MarschallInstitute for Medical Biometry and Bioinformatics, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.ORCID http://orcid.org/0000-0002-9376-1030
Daniel NowakDepartment of Hematology and Oncology, Medical Faculty Mannheim of the Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-7130-7921
Jean-Pierre BourquinDivision of Pediatric Oncology, University Children's Hospital, Zürich, Switzerland.
Andreas E KulozikMolecular Medicine Partnership Unit, European Molecular Biology Laboratory, University of Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-1953-0848
Sascha DietrichDepartment of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
Beat BornhauserDivision of Pediatric Oncology, University Children's Hospital, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-2890-3191
Ashley D SandersGenome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. ashley.sanders@mdc-berlin.de.ORCID http://orcid.org/0000-0003-3945-0677
Jan O KorbelGenome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. jan.korbel@embl.org.ORCID http://orcid.org/0000-0002-2798-3794
Heidelberg University · DEEuropean Molecular Biology Laboratory · DEUniversity Children's Hospital Zurich · CHEuropean Bioinformatics Institute · GBEuropean Molecular Biology Organization · DEGerman Cancer Research Center · DEHeinrich Heine University Düsseldorf · DEMax Delbrück Center · DETata Institute of Fundamental Research · INUniversity of Washington · US

Funding

Identifying and Characterizing the Full Spectrum of Haplotype-resolved Structural Variation in Human GenomesU24HG007497 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Evan Eichler, Jan Oliver Korbel · 2019 to 2026
$17.2M
European Research Council 336045European Research Council 773026NHGRI NIH HHS U24 HG007497
6 · The paper itself

Abstract

Somatic structural variants (SVs) are widespread in cancer, but their impact on disease evolution is understudied due to a lack of methods to directly characterize their functional consequences. We present a computational method, scNOVA, which uses Strand-seq to perform haplotype-aware integration of SV discovery and molecular phenotyping in single cells by using nucleosome occupancy to infer gene expression as a readout. Application to leukemias and cell lines identifies local effects of copy-balanced rearrangements on gene deregulation, and consequences of SVs on aberrant signaling pathways in subclones. We discovered distinct SV subclones with dysregulated Wnt signaling in a chronic lymphocytic leukemia patient. We further uncovered the consequences of subclonal chromothripsis in T cell acute lymphoblastic leukemia, which revealed c-Myb activation, enrichment of a primitive cell state and informed successful targeting of the subclone in cell culture, using a Notch inhibitor. By directly linking SVs to their functional effects, scNOVA enables systematic single-cell multiomic studies of structural variation in heterogeneous cell populations.

Indexed as

ChromothripsisLeukemiaNeoplasmsCell LineGene RearrangementGenomic Structural VariationHumans

Identifiers

PMID36424487
PMCPMC10264249
OpenAlexW4310060314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.